| By PR Newswire |
Article Rating: |
|
| January 17, 2013 01:31 PM EST |
Reads: |
254 |
SAN DIEGO, Jan. 17, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2012 distributions as follows:
|
Security Description: Common Stock
CUSIP: 09063H107
Ticker Symbol: BMR
|
|
Record Date
|
Payable Date
|
Total Distribution
Per Share
|
Allocable to 2012
|
Taxable Ordinary Dividend
|
Return of Capital
|
Long-Term Capital Gain
|
Unrecaptured Section 1250 Gain
|
|
12/30/2011
|
1/17/2012
|
$0.200000
|
$0.200000
|
$0.148244
|
$0.051756
|
$0.000000
|
$0.000000
|
|
3/30/2012
|
4/16/2012
|
$0.215000
|
$0.215000
|
$0.159362
|
$0.055638
|
$0.000000
|
$0.000000
|
|
6/29/2012
|
7/16/2012
|
$0.215000
|
$0.215000
|
$0.159362
|
$0.055638
|
$0.000000
|
$0.000000
|
|
9/28/2012
|
10/15/2012
|
$0.215000
|
$0.215000
|
$0.159362
|
$0.055638
|
$0.000000
|
$0.000000
|
|
Totals
|
$0.845000
|
$0.845000
|
$0.626330
|
$0.218670
|
$0.000000
|
$0.000000
|
|
Security Description: 7.375% Series A Cumulative Redeemable Preferred Stock
CUSIP: 09063H206
Ticker Symbol: BMR PR A
|
|
Record Date
|
Payable Date
|
Total Distribution
Per Share
|
Allocable to 2012
|
Taxable Ordinary Dividend
|
Return of Capital
|
Long-Term Capital Gain
|
Unrecaptured Section 1250 Gain
|
|
12/30/2011
|
1/17/2012
|
$0.460940
|
$0.460940
|
$0.460940
|
$0.000000
|
$0.000000
|
$0.000000
|
|
3/30/2012
|
4/16/2012
|
$0.460940
|
$0.460940
|
$0.460940
|
$0.000000
|
$0.000000
|
$0.000000
|
|
6/29/2012
|
7/16/2012
|
$0.460940
|
$0.460940
|
$0.460940
|
$0.000000
|
$0.000000
|
$0.000000
|
|
9/28/2012
|
10/15/2012
|
$0.460940
|
$0.460940
|
$0.460940
|
$0.000000
|
$0.000000
|
$0.000000
|
|
Totals
|
$1.843760
|
$1.843760
|
$1.843760
|
$0.000000
|
$0.000000
|
$0.000000
|
The distributions payable on January 15, 2013 to shareholders of record on December 31, 2012, as previously declared on December 12, 2012, are considered 2013 distributions for federal income tax purposes.
Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.
About BioMed Realty Trust
BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 13.1 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, Maryland, San Diego, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
SOURCE BioMed Realty Trust, Inc.
